anti-Melanoma Marker (MART-1 + Tyrosinase + gp100), DyLight 755, Clone: A103 + T311 + HMB45, Novus Biologicals™

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP234547IR

Catalog No. NBP234547IR

Description

Melanoma Marker (MART-1 + Tyrosinase + gp100) Monoclonal specifically detects Melanoma Marker (MART-1 + Tyrosinase + gp100) in Human samples. It is validated for Western Blot.

Specifications

• Antigen: Melanoma Marker (MART-1 + Tyrosinase + gp100)
• Classification: Monoclonal
• Conjugate: DyLight 755
• Gene Alias: MART1, MART-1, melan-A, MLANA
• Immunogen: Recombinant hMART-1 protein (A103); Recombinant tyrosinase protein (T311); Extract of pigmented melanoma metastases from lymph nodes (HMB45)
• Quantity: 0.1 mL
• Primary or Secondary: Primary
• Test Specificity: This antibody cocktail recognizes three melanoma-specific proteins, which include MART-1, Tyrosinase and gp100. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Tyrosinase is one of the targets for cytotoxic T-cell recognition in melanoma patients. The function of gp100 is not known but it is reported to be a useful marker for melanocytes and melanomas. This cocktail of three markers is designed for extremely sensitive labeling of formalin-fixed, paraffin-embedded melanomas and other tumors showing melanocytic differentiation.
• Content And Storage: Store at 4C in the dark.
• Isotype: IgG1, IgG2a κ

• Applications: Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen)
• Clone: A103 + T311 + HMB45
• Dilution: Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen
• Host Species: Mouse
• Purification Method: Protein A or G purified
• Regulatory Status: RUO
• Gene ID (Entrez): 2315
• Target Species: Human
• Form: Purified

For Research Use Only